Robert Ross

Robert Ross is the current CEO and Director at Surface Oncology. Robert has held this position since October of 2016. Prior to Surface Oncology, Ross was the Vice President of Clinical Development at bluebird bio from 2012 to 2016. Ross was also the Vice President of Clinical Development at Infinity Pharmaceuticals from 2007 to 2012, and they were a Physician at Dana Farber Cancer Institute from 2002 to 2015. From 2002 to 2003, Ross worked as a Clinical Scientist at Genentech. Lastly, Ross was a Resident in Internal Medicine at UCSF from 1999 to 2002.

Robert Ross completed a BS in Biology and Philosophy from Stanford University. Robert then went on to complete an MS in Medical Science from Harvard University. Finally, they completed an MD in Medicine from Columbia University.

Some individuals on their team include Chandra Adams - VP, Legal, Alison O’Neill - Chief Medical Officer, and Vito Palombella - Chief Scientific Officer.